» Articles » PMID: 6144350

Blocking Activity to Action of Thyroid Stimulating Hormone in Serum from Patients with Primary Hypothyroidism

Overview
Specialty General Medicine
Date 1984 May 26
PMID 6144350
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Spontaneous primary hypothyroidism in adults is usually associated with autoimmune thyroiditis. The hypothesis that hypothyroidism may result from the presence in serum of a factor that blocks stimulation of the thyroid by thyroid stimulating hormone was examined. Serum samples were collected from 28 patients with recently diagnosed primary hypothyroidism. After removal of endogenous thyroid stimulating hormone the effect of the serum on secretion of triiodothyronine induced by thyroid stimulating hormone or thyroid stimulating antibodies was examined in thyroid slices incubated in vitro. Serum samples from six of the patients demonstrated significant blocking of the stimulation by bovine thyroid stimulating hormone. Inhibition of the stimulatory action of thyroid stimulating antibodies was also exhibited by serum samples with blocking activity. It is concluded that in some patients with primary hypothyroidism a serum factor, which is probably an IgG, exists that can block the thyroid response to thyroid stimulating hormone and thyroid stimulating antibodies; it may represent an important mechanism in the pathogenesis of hypothyroidism.

Citing Articles

Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

Chiovato L, Vitti P, Bendinelli G, Santini F, Fiore E, Capaccioli A J Endocrinol Invest. 1994; 17(10):809-16.

PMID: 7699216 DOI: 10.1007/BF03347782.


Myxoedema followed by TSAb-induced hyperthyroidism: report of 2 cases.

Steel N, Bingle J, RAMSAY I, Kendall-Taylor P Postgrad Med J. 1985; 61(718):717-20.

PMID: 2863816 PMC: 2418356. DOI: 10.1136/pgmj.61.718.717.


Antibody that blocks stimulation of cortisol secretion by adrenocorticotrophic hormone in Addison's disease.

Kendall-Taylor P, Lambert A, Mitchell R, Robertson W Br Med J (Clin Res Ed). 1988; 296(6635):1489-91.

PMID: 2839266 PMC: 2546014. DOI: 10.1136/bmj.296.6635.1489.


Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells.

Chiovato L, Vitti P, Lombardi A, Lopez G, Santini F, Macchia E J Endocrinol Invest. 1987; 10(4):383-8.

PMID: 2824596 DOI: 10.1007/BF03348154.


Role of blocking TSH receptor antibodies on the development of hypothyroidism and thyroid atrophy in primary myxedema.

Cho B, Shong Y, Lee H, Koh C, Min H, Sohn I Korean J Intern Med. 1989; 4(2):108-17.

PMID: 2577255 PMC: 4534980. DOI: 10.3904/kjim.1989.4.2.108.

References
1.
Matsuura N, Yamada Y, Nohara Y, Konishi J, Kasagi K, Endo K . Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med. 1980; 303(13):738-41. DOI: 10.1056/NEJM198009253031306. View

2.
Drexhage H, Bottazzo G, Bitensky L, Chayen J, Doniach D . Thyroid growth-blocking antibodies in primary myxoedema. Nature. 1981; 289(5798):594-6. DOI: 10.1038/289594a0. View

3.
Biro J . Specific binding of thyroid-stimulating hormone by human serum globulins. J Endocrinol. 1981; 88(3):339-49. DOI: 10.1677/joe.0.0880339. View

4.
Yavin E, Yavin Z, Schneider M, Kohn L . Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease. Proc Natl Acad Sci U S A. 1981; 78(5):3180-4. PMC: 319524. DOI: 10.1073/pnas.78.5.3180. View

5.
Konishi J, Iida Y, Endo K, Misaki T, Nohara Y, Matsuura N . Inhibition of thyrotropin-induced adenosine 3'5'-monophosphate increase by immunoglobulins from patients with primary myxedema. J Clin Endocrinol Metab. 1983; 57(3):544-9. DOI: 10.1210/jcem-57-3-544. View